Enhertu Gets Accelerated Approval for HER2-Expressing Solid Tumors – Renal and Urology News
The approval was based on data from 3 clinical trials: DESTINY-PanTumor02, DESTINY-Lung01, and DESTINY-CRC02.
The approval was based on data from 3 clinical trials: DESTINY-PanTumor02, DESTINY-Lung01, and DESTINY-CRC02.
The sBLA included clinical immunogenicity and safety data from the phase 1 HBV-24 study.
Results of a meta-analysis support the use of ketoconazole for patients with previously treated castration-resistant prostate cancer. Results of a meta-analysis support the use of…
Higher risk for cardiovascular mortality, kidney disease progression seen with serum 25(OH)D <10 ng/mL
Dr. Andrew Lai, a University of Illinois College of Medicine Co-Chief Resident and author of the AUANews article, “My Journey as an Out and Proud…
Preliminary results from the CUPID study were based on data from 11 evaluable patients with advanced prostate cancer.
This is among the few studies specifically examining outcomes of patients with critical limb ischemia and ESKD receiving dialysis.
“Certainly, there are more and more radioligands coming out not only in prostate cancer, but in other cancers related to urology, and I think that’s…
Findings independent of diabetes duration over a 10-year period
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
The European Association of Urology (EAU) Renal Transplantation Guidelines aim to provide a comprehensive overview of the medical and technical aspects relating to renal transplantation.